Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

ATOS 0.960 +0.006 (0.63%)
price chart
Atossa Genetics Inc. Provides Update on Pharmacogenetics Testing Now ...
SEATTLE, WA, Dec 19, 2014 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, -0.08% today announced that its subsidiary, The National Reference Laboratory for Breast Health, Inc. (the NRLBH), a CLIA-certified laboratory located in Seattle, ...
Related articles »  
Atossa Genetics Inc. Announces Successful Closure of FDA Inspections
SEATTLE, WA, Dec 05, 2014 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, -5.54% today announced that it has received "establishment inspection reports," or EIRs, from the U.S.
Atossa Genetics touts 'successful closure of FDA inspections'  Puget Sound Business Journal (Seattle) (blog)
Related articles »  
Atossa Genetics gets bad news from FDA, shares dive
In early Wednesday pre-market trading, shares in Atossa Genetics (NASDAQ: ATOS) had fallen more than 50 percent, dropping $1.23 to $1.10.
Atossa Genetics Inc (NASDAQ:ATOS) To Focus On Commercial Launch Of ...  USMarketsDaily
7 Big Slumps: Atossa Genetics (ATOS), Baxano Surgical (BAXS), Chinanet ...  Markets Emerging
Related articles »  
Atossa Genetics Inc. Announces Contract With Rhenus Advanced Services B.V.
Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has contracted with Rhenus Advanced Services B.V. to provide comprehensive logistics services and support in European markets.
Related articles »  
Atossa Genetics Inc. Hires Pieter van der Poel as Vice President of European ...
SEATTLE, WA--(Marketwired - Dec 16, 2014) - Atossa Genetics Inc. ( NASDAQ : ATOS) today announced that it has hired Pieter van der Poel as Vice President of European Commercial Operations effective December 15, 2014.
Related articles »  
Atossa Genetics Inc (ATOS): Atossa Genetics -15% on heels of critical FDA report
Atossa Genetics (ATOS -15.3%) slides sharply after the Food and Drug Administration issues a consumer update on nipple aspirators used for breast cancer screening, saying a mammogram is still the best way to detect breast cancer.
Related articles »  
Atossa Genetics Inc (ATOS): An Expanding Distribution Infrastructure Augurs ...
(Editors' Note: This article covers a micro-cap stock. Please be aware of the risks associated with these stocks.) The shares of Atossa Genetics, Inc. (ATOS) soared 21.0% on September 19th on more than 37-times the normal daily trading volume. At its ...
Atossa Genetics: My Top Biotech Idea For 2013
Analogously, Atossa just announced that it has entered into a contractual agreement with FedMed, Inc., one of the largest proprietary Preferred Provider Organization (PPO) networks in the U.S.
Seattle breast cancer test company Atossa Genetics brings on new VP of ...
Youmans' hire comes at a pivotal time for the company. Atossa Genetics has been working to quell concerns the U.S.
Atossa Genetics Inc. Hires Scott Youmans as Senior Vice President of Operations  Marketwired (press release)
Related articles »  
Atossa Genetics: Room For Further Price Appreciation
Atossa Genetics (NASDAQ:ATOS) is a medical diagnostics company focused on the prevention of breast cancer through the development and commercialization of diagnostic tests which can detect precursors to breast cancer.